Nussloch

Leica Biosystems is a cancer diagnostics and medical technology company focused on anatomic pathology workflow solutions. The company provides instruments, consumables, assays, software, digital pathology systems, and workflow services that support tissue processing, staining, slide scanning, image management, and pathology interpretation. Its business is centered on helping pathology laboratories improve efficiency and diagnostic quality, particularly in oncology and biomarker testing. Leica Biosystems operates globally and is part of Danaher’s diagnostics portfolio. Rather than a therapeutic drug developer, it is a commercial-stage diagnostics and workflow company serving clinical laboratories, hospitals, researchers, and biopharma partners.